TRULY INDEPENDENT RESEARCH?

摘要

Drug and medical device companies are increasingly outsourcing clinical trials to commercial and academic contract research organisations (CROs). As well as cutting costs, this could potentially put desperately needed distance between sponsor and research product. If achieved, such distancing couldn't come at a better time: a Harris Interactive poll shows that of the top 11 industry sectors, only tobacco companies had higher negative public opinion ratings than drug companies (76% and 52%, respectively).